[April 17, 2014]

Research and Markets: Global Hormone-Sensitive Prostate Cancer Global Clinical Trials Review 2014 - Profiles of 16 Top Organisations

Research and Markets (http://www.researchandmarkets.com/research/fdbpb3/hormonesensitive) has announced the addition of the "Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014" report to their offering.

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014 provides data on the Hormone-Sensitive Prostate Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hormone-Sensitive Prostate Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drus for treating Hormone-Sensitive Prostate Cancer.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Top Companies/Organisations Participating in Hormone-Sensitive Prostate Cancer Therapeutics Clinical Trials

• Novartis AG
• Ferring International Center S.A.
• Johnson & Johnson
• GlaxoSmithKline plc
• Dendreon Corporation
• CMX Research Inc.
• National Cancer Institute
• Massachusetts General Hospital
• University of California, San Francisco
• Azienda Provinciale per i Servizi Sanitari
• Comprehensive Cancer Centers of Nevada
• City of Hope National Medical Center
• Oslo University Hospital
• Keio University
• Barbara Ann Karmanos Cancer Institute
• University of Pennsylvania

For more information visit http://www.researchandmarkets.com/research/fdbpb3/hormonesensitive

[ Back To TMCnet.com's Homepage ]